Prot# 666E-CNS-0618-001: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Efficacy and Safety of Sumanirole in Patients with Idiopathic Restless Legs Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date6/25/0312/6/06

Funding

  • Pharmacia & Upjohn, Inc. (666E-CNS-0618-001)